MW

Michael Winlo

Emyria Limited | Managing Director
Mr Winlo, prior Emyria, Michael was CEO and a Director at Linear Clinical Research Ltd (Linear) providing clinical trial services for US - and Asia based biotech companies. Linear was the first site in Australia and one of only a few in the world to adopt electronic data capture technology. Prior to Linear, Michael was Health Lead at Palantir Technologies - a Big Data company based in Silicon Valley California.

Company and Role

Company
Title
Tenure
Since
EMD
EMD
Emyria Limited
  • Managing Director
6yrs, 8mthNov 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
EMD
EMD
Emyria Limited
22/09/251,324,230N/A5,743,761N/A
NVU
NVU
15/06/252,386,154N/A0N/A
DVL
DVL
15/11/243,251,940N/A454,545N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
EMD
EMD
Emyria Limited
28/05/26
Issued
4,500,000$0.045$202,500Issue of securities
EMD
EMD
Emyria Limited
22/09/25
Issued
331,058$0.055$18,208Prospectus
EMD
EMD
Emyria Limited
29/08/25
Issued
69,444$0.048$3,333Placement
EMD
EMD
Emyria Limited
29/08/25
Issued
208,333$0.024$4,999Placement
NVU
NVU
30/05/25
Exercise
2,040,000$0.048$97,920Conversion of securities